Spots Global Cancer Trial Database for end stage renal disease
Every month we try and update this database with for end stage renal disease cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary Hyperparathyroidism | NCT01149291 | Secondary Hyper... End Stage Renal... | 18 Years - | AbbVie | ||
The Singapore Chinese Health Study | NCT03356340 | Cancer End Stage Renal... Diabetes Cardiovascular ... | 45 Years - 74 Years | Duke-NUS Graduate Medical School | ||
Meals MATTER: A Trial of Medically Tailored Meals 2 Weeks vs. 4 Weeks Post Hospital Discharge | NCT04351880 | Heart Failure Copd Liver Failure Diabetes Mellit... Cancer End Stage Renal... | Medically Tailo... | 18 Years - | Kaiser Permanente | |
Meals MATTER: A Trial of Medically Tailored Meals 2 Weeks vs. 4 Weeks Post Hospital Discharge | NCT04351880 | Heart Failure Copd Liver Failure Diabetes Mellit... Cancer End Stage Renal... | Medically Tailo... | 18 Years - | Kaiser Permanente | |
The Singapore Chinese Health Study | NCT03356340 | Cancer End Stage Renal... Diabetes Cardiovascular ... | 45 Years - 74 Years | Duke-NUS Graduate Medical School | ||
The Singapore Chinese Health Study | NCT03356340 | Cancer End Stage Renal... Diabetes Cardiovascular ... | 45 Years - 74 Years | Duke-NUS Graduate Medical School | ||
A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Dialysis Patients | NCT00037635 | Secondary Hyper... End Stage Renal... | AMG 073 Placebo | 18 Years - | Amgen | |
Combined Bone Marrow Transplantation (BMT) and Renal Transplant for Multiple Myeloma (MM) With End Stage Renal Disease (ESRD) | NCT00854139 | Multiple Myelom... End Stage Renal... | Cyclophosphamid... Kidney transpla... Thymic irradiat... Bone marrow tra... | 18 Years - 65 Years | Massachusetts General Hospital | |
Comparative Trial of Home-Based Palliative Care | NCT03694431 | Cancer Chronic Obstruc... Heart Failure Dementia End Stage Liver... End Stage Renal... Neuromuscular D... | Tech-supported ... Standard HBPC | 18 Years - | Kaiser Permanente | |
Efficacy and Safety of Alfacalcidol Compared to Calcitriol for Treatment of Secondary Hyperparathyroidism | NCT01115543 | Secondary Hyper... End Stage Renal... | alfacalcidol an... | 18 Years - | Mahidol University | |
A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Patients on Dialysis | NCT00042653 | Secondary Hyper... End Stage Renal... | Placebo AMG 073 | 18 Years - | Amgen | |
Combined Bone Marrow and Kidney Transplant for Multiple Myeloma With Kidney Failure | NCT00062621 | Kidney Failure,... Multiple Myelom... | Combined bone m... | 18 Years - 65 Years | National Institute of Allergy and Infectious Diseases (NIAID) | |
Efficacy and Safety of Alfacalcidol Compared to Calcitriol for Treatment of Secondary Hyperparathyroidism | NCT01115543 | Secondary Hyper... End Stage Renal... | alfacalcidol an... | 18 Years - | Mahidol University | |
Efficacy and Safety of High Intensity Focused Ultrasound (HIFU) Device to Treat Secondary Hyperparathyroidism | NCT01421407 | Secondary Hyper... End Stage Renal... Parathyroid Hyp... | Ultrasonic abla... | 18 Years - | Theraclion | |
Reducing Disparities in the Quality of Advance Care Planning for Older Adults | NCT03516994 | Metastatic Canc... Congestive Hear... Chronic Obstruc... Parkinson Disea... Interstitial Lu... Amyotrophic Lat... End Stage Liver... End Stage Renal... Diabetes Compli... | Respecting Choi... Five Wishes For... | 65 Years - | Duke University |